Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Resu

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Related Keywords

United States , Netherlands , Holland , America , Robertg Shawah , Davidp Luci , , Paycheck Protection Program Loan , Prnewswire Acurx Pharmaceuticals Inc , Drug Administration , Nasdaq , Exchange Commission , C Diff Foundation Conference , Exchange Commission On Form , Acurx Pharmaceuticals , Anaerobe Society Of America , Acurx Pharmaceuticals Inc , Leiden University Medical Center Holland , University Of Houston , Leiden University Medical Center , Anaerobe Society , Antimicrobial Resistance Conference , Diff Foundation Conference , Chief Executive Officer , Chief Financial Officer , Gram Positive Selective Spectrum , Qualified Infectious Disease Product , Generating New Antibiotic Incentives Now , Looking Statements , Private Securities Litigation Reform Act , Paycheck Protection Program , Nc ,